Latest news
25 items- 13D/GSEC Form SC 13D filed by Big Cypress Acquisition Corp.SC 13D - SAB Biotherapeutics, Inc. (0001833214) (Subject)
- 13D/GSEC Form SC 13D filed by Big Cypress Acquisition Corp.SC 13D - SAB Biotherapeutics, Inc. (0001833214) (Subject)
- 13D/GSEC Form SC 13D filed by Big Cypress Acquisition Corp.SC 13D - SAB Biotherapeutics, Inc. (0001833214) (Subject)
- SECBig Cypress Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits, Unregistered Sales of Equity Securities, Changes in Registrant’s Certifying Accountant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Leadership Update, Change in Shell Company Status8-K - SAB Biotherapeutics, Inc. (0001833214) (Filer)
- INSIDERSEC Form 4 filed by Carillo Carlos N4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
- INSIDERSEC Form 4 filed by Erickson Bruce Kipp4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
- INSIDERSEC Form 4 filed by Wu Hua4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
- INSIDERSEC Form 4 filed by Polvino William James4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
- INSIDERSEC Form 4: Finnegan Frederick was granted 38,596 shares4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
- INSIDERSEC Form 4: Hamilton Edward D. was granted 10,102,435 shares4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
- INSIDERSEC Form 4: Luke Thomas Charles was granted 6,418 shares4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
- INSIDERSEC Form 4: Sullivan Eddie Joe was granted 5,216,564 shares4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
- INSIDERSEC Form 4 filed by Turner Mervyn4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
- INSIDERSEC Form 4: Link David Charles was granted 27,917 shares4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
- INSIDERSEC Form 4 filed by Bausch Christoph Lawrence4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
- INSIDERSEC Form 4 filed by Ullerich Melissa Vera4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
- INSIDERSEC Form 4: Hamilton Christine E was granted 10,102,435 shares4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
- INSIDERSEC Form 4 filed by Pommer Jerry Lynn4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
- INSIDERSEC Form 4 filed by Randall Charles Hiram4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
- INSIDERSEC Form 3 filed by new insider Turner Mervyn3 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
- PRSAB Biotherapeutics Debuts as Publicly Traded Next-Generation Immunotherapy CompanyCompleted Business Combination with Big Cypress Acquisition Corp. Common stock to commence trading on the Nasdaq Global Market October 25, 2021, under the ticker symbol "SABS" SIOUX FALLS, S.D., Oct. 25, 2021 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (NASDAQ:SABS), (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human polyclonal antibodies without the need for human donors, today announced the completion of its business combination with Big Cypress Acquisition Corp. (NASDAQ:BCYP) ("Big Cypress"), a publicly-traded special purpose acquisition company (SPAC) focused on innovative biopharmaceutical
- INSIDERSEC Form 3 filed by new insider Finnegan Frederick3 - Big Cypress Acquisition Corp. (0001833214) (Issuer)
- INSIDERSEC Form 3: New insider Hamilton Edward D. claimed ownership of 78,587 shares3 - Big Cypress Acquisition Corp. (0001833214) (Issuer)
- INSIDERSEC Form 3 filed by new insider Bausch Christoph Lawrence3 - Big Cypress Acquisition Corp. (0001833214) (Issuer)
- INSIDERSEC Form 3 filed by new insider Carillo Carlos N3 - Big Cypress Acquisition Corp. (0001833214) (Issuer)
BCYP FAQ
5 questionsWhat does Big Cypress Acquisition Corp. do?
Big Cypress Acquisition Corp. does not have significant operations. The company intends to acquire assets and businesses through a merger, capital stock exchange, stock purchase, reorganization, or similar business combination. It primarily focuses in the life science sector. The company was incorporated in 2020 and is based in Miami Beach, Florida.Where does BCYP stock trade?
Big Cypress Acquisition Corp. (BCYP) is listed on NASDAQ.What sector and industry is BCYP in?
Big Cypress Acquisition Corp. operates in the Finance sector.What are analysts saying about BCYP?
Big Cypress Acquisition Corp. has had 2 recent analyst actions on file. The most recent action was from Northland Capital Markets: Outperform with a $1800.00 price target on 2021-10-04. Recent price targets range from $1650.00 to $1800.00.How can I track BCYP on Quantisnow?
Quantisnow aggregates Big Cypress Acquisition Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BCYP to receive live email and push alerts on every new disclosure.